NHS Specialist Pharmacy Service Medicine Use Reviews NSAIDs NHS Specialist Pharmacy Service Medicines Use & Safety.

Slides:



Advertisements
Similar presentations
Safer IT Systems for the NHS Dr. Maureen Baker CBE DM FRCGP Special Clinical Adviser NPSA Clinical Safety Officer CfH.
Advertisements

Derek Feeley Director General and Chief Executive, NHSScotland.
Patient Public Involvement (PPI) Policy What is PPI? PPI means putting patients and public at the centre of all that we do. It encourages the active participation.
INDIGESTION (DYSPEPSIA) AND HEARTBURN (ACID REFLUX)
NSAIDs and GI and Renal Complications Lessons from Tennessee Medicaid population studies (and selected others)
Walsall Healthcare NHS Trust Medicines Management.
Fylde Coast Integrated Diabetes Care
Protecting patients- now and in the future Linda Matthew Senior Pharmacist National Patient Safety Agency.
Managing Medicines Use by PBC Groups in West Hertfordshire Dr Alison Davies.
Medicines Optimisation How can data help us to get it right?
1 “Medicines use review conducted in community pharmacy" Professor Ian Chi Kei Wong Department of Health Public Health Career Scientist The School of Pharmacy.
OPTIMISING MEDICINES USE GRAHAM DAVIES Professor of Clinical Pharmacy & Therapeutics Institute of Pharmaceutical Science King’s College London.
Think Pharmacy Sue Sharpe CEO PSNC. Outline of Talk The Vision for the future community pharmacy The four domains for pharmacy services  Medicines Optimisation.
Safer Medication & Medical Devices Medication Safety & Hospital Admissions Avoidance 30 th June 2015 Dr Ahmed Ameer Medication Safety.
Discharge planning – reducing admissions/re- admissions Jo Clarke, CPPE tutor 1.
The London Older People Service Development Program (LOPSDP) The ‘Medicines Management’ Project (January to July 2003) Lelly Oboh Project Co-ordinator.
Sexual Health Service by Community Pharmacists Kate Kinsey NHS Manchester.
E-Health Workshop Session 1: Empowering patients, carers and members of the public to look after their own health Delivering Better Health Services – The.
Can we afford to waste medicines? - update on possible national strategies Bhulesh Vadher Clinical Director of Pharmacy and Medicines Management, Oxford.
Commissioning Intentions for 2015/16 Paul Sinden, Director of Commissioning.
Implementing NICE guidance
NICE Decision Making Dr Katherine Payne North West Genetics Knowledge Park The University of Manchester
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
TORFAEN MEDICATION ADMINISTRATION SCHEME Val Bessell Wendy Tyler-Batt.
Personalisation in the NHS Giles Wilmore Director NHS England
Shared Decision Making MAGIC — Making Good decisions In Collaboration — Shared decision making the norm — Multi-centre, large scale implementation programme.
Falls Prevention & Inhaler Service Update Training Claire Thomas.
Medication Safety and admissions avoidance: A perspective Steve Williams Consultant Pharmacist in Medicine & Medication Safety Honorary Clinical Lecturer,
The benefits of Community Pharmacy delivering Vascular Risk Assessments.
NPS MEDICINEWISE Lynn Weekes Chief Executive.
Improving the effectiveness of integrated care teams Rob Darracott Pharmacy Voice.
BHIVA PROMS / PREMS PROJECT A Community Consultation.
2015/16 NHS Pre-registration Trainee Pharmacist Programme Proposed Themes The Programme will consist of 4 interconnecting themes with emphasis on direct.
UNDERSTANDING AND DEFINING QUALITY Quality Academy – Cohort 6 April 8, 2013.
Community Pharmacy Cheshire & Wirral (CPCW) Helen Murphy Chief Executive Officer Community Pharmacy Cheshire and Wirral.
Summary Pattern of Specific COX II Inhibitors Use Physician prescribed appropriate COX II use in high risk was 40.08% and inappropriate COX II use in low.
Community Pharmacy Presentation for Hospital Pharmacists July 2015.
NSAIDs.
South Central Respiratory Project MK Report 10 th October 2011 Nikki Hughes Community Pharmacy Lead NHS Milton keynes.
Medicines Optimisation Polypharmacy and Deprescribing
2011 & 2012 PCPA and RPS Research Topline Results.
What about VIOXX?. Adenomatous Polyp Prevention on Vioxx (APPROVe) Vioxx (rofecoxib) versus Placebo Basic Clinical Trial Objective: Assess whether Vioxx.
Hot Topic Presentation Lars Halford, GP ST3 March 2010
An unpleasant sensory or emotional experience associated with actual or potential tissue damage The World Health Organization (WHO) has stated that pain.
Putting Patients at the Centre of Care What can my Community Pharmacist do for me? Dr Tarlochan Gill Chairman, Kent & Medway Pharmacy Local Professional.
East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast NSAIDS – Efficacy and Safety Expert speaker.
Educational solutions for the NHS pharmacy workforce Medicines Optimisation: Helping patients to make the most of medicines Sue Carter Regional Tutor
Workshop to introduce local selection of monographs from national midwifery formulary.
The Medicines Adherence and Waste Challenge Carol Roberts Director of Strategic Prescribing EAHSN and PrescQIPP.
Vascular Surgery in Thames Valley Dr Will Orr Clinical Lead CVD Thames Valley NHS England 1.
Medicines Optimisation Putting Patients at the Centre of their Care Jabeen Egan Lead Pharmacist.
S Medicine Use Reviews NSAIDs NHS Specialist Pharmacy Services Medicines Use & Safety P S East & South East England Specialist Pharmacy Services East of.
Private and confidential Community Pharmacy Future Four-or-more medicines support service Update on progress and next steps Approved18 th June 2012 This.
East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast Medicine Use Reviews NSAIDs NHS Specialist.
European Community Pharmacy Blueprint A perspective from general practice Professor Tony Avery.
Improving medicines adherence and reducing medicines waste: EAHSN/PrescQIPP- Strategy to develop joint working programme with the Pharmaceutical.
Pharmacy White Paper Building on Strengths Delivering the Future Overview.
NHS Specialist Pharmacy Service NSAIDS – efficacy and safety Expert speaker Slide set Key content from the NPC NSAIDS QIPP slides is gratefully acknowledged.
Clinical Knowledge Summaries CKS Analgesia – mild to moderate pain Prescribing analgesics for mild to moderate pain in adults and children. Educational.
Graph to show the number of patients receiving management options
Liz Corteville, Medicines Optimisation
Cyclooxygenase Inhibitors: Nonsteroidal Anti-Inflammatory Drugs and Acetaminophen 1.
Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis.
  Scottish Patient Safety Programme in Primary Care (SPSP – PC) Implementation & Spread Strategy 2013–2018.
  Implementing the Scottish Patient Safety Programme in Primary Care (SPSP – PC)
Medicines Safety Programme
Commissioning Intentions - Planned Care Workstream
Claire Vaughan- Head of Medicines Optimisation, Salford CCG
Presentation transcript:

NHS Specialist Pharmacy Service Medicine Use Reviews NSAIDs NHS Specialist Pharmacy Service Medicines Use & Safety

NHS Specialist Pharmacy Service Introduction and welcome Housekeeping –Fire drills –Facilities –Refreshments

NHS Specialist Pharmacy Service Programme Objectives and warm-up Expert presentation Activities NSAID MUR and audit project presentation Activities Action plan and close

NHS Specialist Pharmacy Service Objectives To revise and update your knowledge of NSAID efficacy and safety problems To develop communication and clinical skills to enhance the NSAID targeted MURs To understand how NSAID MURs have been used to improve NSAID safety To improve outcomes for patients taking NSAIDs To increase the number and efficacy of NSAID targeted MURs locally

NHS Specialist Pharmacy Service Warm-up Write down on a sticky note a number from 1-10 where 1 is not confident in doing MURs and 10 is very confident What is the biggest barrier for you doing MURs?

NHS Specialist Pharmacy Service Key facts quiz 10 questions seconds to discuss each answer in your groups

NHS Specialist Pharmacy Service Question 1 Are COX-2 selective inhibitors more effective than traditional NSAIDs?

NHS Specialist Pharmacy Service Answer to question 1 Are COX-2 selective inhibitors more effective than traditional NSAIDs? NO Similar efficacy to traditional NSAIDs such as diclofenac and naproxen.

NHS Specialist Pharmacy Service Question 2 Does NICE guidance on osteoarthritis recommend use of topical NSAIDs?

NHS Specialist Pharmacy Service Answer to question 2 Does NICE guidance on osteoarthritis recommend use of topical NSAIDs? YES These should be considered before oral NSAIDs or opioids.

NHS Specialist Pharmacy Service Question 3 Can ranitidine be used to prevent NSAID-induced ulcers?

NHS Specialist Pharmacy Service Answer to question 3 Can ranitidine be used to prevent NSAID-induced ulcers? YES But standard doses are not effective and PPIs are preferred.

NHS Specialist Pharmacy Service Question 4 Can misoprostol be used to prevent NSAID-induced ulcers?

NHS Specialist Pharmacy Service Answer to question 4 Can misoprostol be used to prevent NSAID-induced ulcers? YES But misoprostol tends to be poorly tolerated.

NHS Specialist Pharmacy Service Question 5 Should OTC omeprazole be used to prevent NSAID-induced ulcers?

NHS Specialist Pharmacy Service Answer to question 5 Should OTC omeprazole be used to prevent NSAID-induced ulcers? NO OTC omeprazole is only licensed for heartburn and acid reflux.

NHS Specialist Pharmacy Service Question 6 Should exercise be a core treatment for people with osteoarthritis, regardless of age and pain severity?

NHS Specialist Pharmacy Service Answer to question 6 Should exercise be a core treatment for people with osteoarthritis, regardless of age and pain severity? YES NICE advises exercise for all (irrespective of age, co-morbidity, pain or disability) and weight loss if overweight or obese.

NHS Specialist Pharmacy Service Question 7 Does NICE recommend using glucosamine in treatment of osteoarthritis?

NHS Specialist Pharmacy Service Answer to question 7 Does NICE recommend using glucosamine in treatment of osteoarthritis? NO The use of glucosamine or chondroitin products is not recommended for the treatment of osteoarthritis. Rubefacients are not recommended either.

NHS Specialist Pharmacy Service Question 8 Has use of naproxen increased because it has fewer GI adverse effects than other NSAIDs (eg diclofenac)?

NHS Specialist Pharmacy Service Answer to question 8 Has use of naproxen increased because it has fewer GI adverse effects than other NSAIDs (eg diclofenac)? NO Use has increased but this is because it appears to have lower cardiovascular risk than other NSAIDs, not lower GI risk.

NHS Specialist Pharmacy Service Question 9 Can NSAIDs be taken with methotrexate?

NHS Specialist Pharmacy Service Answer to question 9 Can NSAIDs be taken with methotrexate? Yes But NSAIDs reduce excretion of methotrexate so increase the toxicity. The dose of methotrexate needs to be carefully monitored and OTC NSAIDs avoided.

NHS Specialist Pharmacy Service Question 10 Is oral diclofenac available over the counter?

NHS Specialist Pharmacy Service Answer to question 10 Is oral diclofenac available over the counter? NO In January 2015 the MHRA issued a Drug Safety Update which changed the legal status of diclofenac and it is now only available as a prescription only medicine.

NHS Specialist Pharmacy Service Expert presentation

NHS Specialist Pharmacy Service Activity one – your NSAID patients In your groups discuss pre-workshop task three. Did you manage to find three patients with regular NSAIDs? Any of these over 75? Any of these with no gastroprotection? Have you done an MUR on any of these patients?

NHS Specialist Pharmacy Service Activity two – consultation skills In your groups discuss the pre-workshop task two. Discuss the questions you wrote down that relate to MURs and the 4Es practice tool Explore Educate Empower Enable

NHS Specialist Pharmacy Service Presentation NSAID MUR and audit project

NHS Specialist Pharmacy Service Medicines-related hospital admissions 6% of admissions due to problems with medicines Mostly preventable Most commonly NSAIDs, diuretics, anticoagulants and antiplatelets Howard R L et al. Quality and Safety in Health Care 2003;12:

NHS Specialist Pharmacy Service Principles for MUR high-risk drugs list ‘Type of harm could be prevented by an MUR and the pharmacist will have the skills, knowledge and information to deliver it.’ services/murs/national-target-groups-for-murs

NHS Specialist Pharmacy Service NSAIDs and preventable admissions LACK OF MONITORING –Renal necrosis PRESCRIBING ISSUES –GI bleed – 2+ risk factors no GI prophylaxis prescribed ADHERENCE ISSUES –GI bleed – not taking GI prophylaxis –GI bleed – self-medicating with OTC NSAIDs

NHS Specialist Pharmacy Service Isn’t NSAID safety fixed already? Survey of 100 MURs NSAIDs patients aged over 55 – 36% no GI protection OA patient survey % not offered GI prophylaxis Community pharmacy audit ,838 (27.5%) patients had used NSAIDs regularly for more than two months and had no gastrointestinal protection

NHS Specialist Pharmacy Service Business case Put together in summer 2010 Support from CCG, PCT, LPC Information to all local GPs and CPs Educational grant from Pfizer

NHS Specialist Pharmacy Service The NSAID MUR Regular prescription for NSAID Focus GI safety Two patient groups at particular risk of NSAID adverse events: 1.Inadequate GI prophylaxis 2.Over 55s

NHS Specialist Pharmacy Service Data collection Smart-survey.co.uk or paper copy Show NSAID MURs being done Demonstrate value, ie, preventing adverse events and admissions

NHS Specialist Pharmacy Service Results 17 pharmacies involved (all types) 15 months (Jan 11 – Mar 12) 142 patients (mean age 64) –1% prescribed two NSAIDs –8% patients taking OTC and prescribed NSAIDs –3% patients taking other GI risk drugs

NHS Specialist Pharmacy Service Inadequate GI prophylaxis 4 non-adherent to GI prophylaxis 82 no GI prophylaxis Collected follow-up data on 48 patients –23 (48%) GI prophylaxis started –7 (15%) NSAID stopped –4 (8%) reduced/less frequent NSAID dose –8 (17%) prescriber/patient active decision not to change –6 (12%) no change

NHS Specialist Pharmacy Service Examples 91-year-old lady prescribed two NSAIDs, low dose aspirin but no PPI Patient stopped taking lansoprazole because of upset stomach, prescriber was unaware 85-year-old lady on ibuprofen referred to GP regarding GI risk, prescribed omeprazole

NHS Specialist Pharmacy Service Overview of results NSAID MURS 63% had NSAID safety issue identified 7% improved safety during MUR (eg, OTC NSAIDs identified or non-adherence to prophylaxis) Post-MUR follow-up of GI safety 71% changed to improve safety Livingstone C, Patel C J, Sinha R and Greensmith S. Evaluation of targeted MURs in preventing avoidable harm from NSAIDs. IJPP 2012;20(2): 71.

NHS Specialist Pharmacy Service CPPE and ‘Just One Patient’ – 1,298 who attended CPPE NSAID safety workshops recorded ‘just one’ NSAID patient on the Smart Survey 159 of these patients 82 aged over 55 with no GI protection 15 also self-medicating with NSAID 77 referred to GP for safety review

NHS Specialist Pharmacy Service 1,278 community pharmacies across England 16,366 patients prescribed NSAIDs 28% regular NSAIDs without GI protection More than 2,000 patients referred to GP

NHS Specialist Pharmacy Service 17 million NSAIDs prescriptions in England each year….

NHS Specialist Pharmacy Service Activity three – case studies In your groups discuss the three case studies. You only have about 3-4 minutes for each one. Feedback at the end.

NHS Specialist Pharmacy Service Activity four – engaging with prescribers In your groups discuss what you will now do to engage with GPs with regard to NSAID MURs Discuss how you might improve the feedback you get from GPs after you send MUR information. Share hints and tips about good ways of linking with GP surgeries.

NHS Specialist Pharmacy Service NSAID audit NSAID safety clinical audit templateNSAID safety clinical audit template Available to downloadAvailable to download Use it to meet the contract requirementsUse it to meet the contract requirements

NHS Specialist Pharmacy Service Action plan What are you going to do as a result of this learning? –Tomorrow or as soon as you return to work –Within a few weeks –Within a longer period (may involve further learning or accreditation)

NHS Specialist Pharmacy Service Reminder of objectives To revise and update your knowledge of NSAID efficacy and safety problems To develop communication and clinical skills to enhance the NSAID targeted MURs To understand how NSAID MURs have been used to improve NSAID safety To improve outcomes for patients taking NSAIDs To increase the number and efficacy of NSAID targeted MURs locally

NHS Specialist Pharmacy Service Confidence ladder Do you feel more confident? Have you climbed the confidence ladder?

NHS Specialist Pharmacy Service Thank you Safe journey home